Rhumbline Advisers Kazia Therapeutics LTD Transaction History
Rhumbline Advisers
- $103 Billion
- Q1 2024
A detailed history of Rhumbline Advisers transactions in Kazia Therapeutics LTD stock. As of the latest transaction made, Rhumbline Advisers holds 12,170 shares of KZIA stock, worth $2,555. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,170
Previous 9,710
25.33%
Holding current value
$2,555
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KZIA
# of Institutions
12Shares Held
323KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY198KShares$41,5480.0% of portfolio
-
Hsbc Holdings PLC London, X064KShares$13,4300.0% of portfolio
-
Xtx Topco LTD London, X018.5KShares$3,8820.0% of portfolio
-
Two Sigma Securities, LLC New York, NY18.4KShares$3,8690.0% of portfolio
-
Ground Swell Capital, LLC Folly Beach, SC11.2KShares$2,3410.0% of portfolio
About KAZIA THERAPEUTICS LTD
- Ticker KZIA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,111,300
- Market Cap $3.17M
- Description
- Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...